Publications by authors named "Alec Lynch"
Article Synopsis
- * The trial included 28 patients and showed promising results with an overall response rate of 82%, and a complete response rate of 71%, especially in a subgroup treated with a low dosage of CAR T cells (25×10).
- * With a median follow-up of 24 months, the therapy demonstrated a 1-year event-free survival rate of 61%, while serious side effects were relatively low, indicating the potential for this approach in treating
